Dyadic’s Revolutionary Animal-Free Bovine Serum Albumin to Solve Costs and Ethical Challenges of Cultivated Meat and Pharmaceuticals
Biotechnology company Dyadic International, Inc. (NASDAQ: DYAI) announces that independent analysis has confirmed that its revolutionary animal-free bovine serum albumin is structurally identical to commercial animal albumin, opening new commercialization opportunities. Bovine serum albumin (BSA) is universal in the pharmaceutical industry. It has applications for human therapeutics, cell culture media, diagnostic test kits, PCR, vaccine development, R&D, and more. Additionally, it is frequently used as a component of the cell …